<h4>Background</h4>Alzheimer's disease (AD) has a strong genetic component, with APOE ε4 being the most established risk factor through its effects on beta-amyloid (Aβ) metabolism and microglial function. This evidence concerns the gene APOE and Alzheimer disease.